|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114.
2016.PubMed/NCBI
|
|
4
|
Gaedcke J, Grade M, Camps J, Søkilde R,
Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi
BM, Møller S, et al: The rectal cancer microRNAome - microRNA
expression in rectal cancer and matched normal mucosa. Clin Cancer
Res. 18:4919–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Merika E, Saif MW, Katz A, Syrigos K and
Morse M: Review. Colon cancer vaccines: An update. In Vivo.
24:607–628. 2010.PubMed/NCBI
|
|
7
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xi ZW, Xin SY, Zhou LQ, Yuan HX, Wang Q
and Chen KX: Downregulation of rho-associated protein kinase 1 by
miR-124 in colorectal cancer. World J Gastroenterol. 21:5454–5464.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura Y, Nishi M, Fukuda Y, Ogino M and
Kosuga H: Case of the multiple liver metastases from colon cancer
obtained long-term disease-free survival with multimodality
therapy. Gan To Kagaku Ryoho. 39:2228–2230. 2012.(In Japanese).
PubMed/NCBI
|
|
10
|
Luo N, Guo J, Chen L, Yang W, Qu X and
Cheng Z: ARHGAP10, downregulated in ovarian cancer, suppresses
tumorigenicity of ovarian cancer cells. Cell Death Dis.
7:e21572016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teng JP, Yang ZY, Zhu YM, Ni D, Zhu ZJ and
Li XQ: The roles of ARHGAP10 in the proliferation, migration and
invasion of lung cancer cells. Oncol Lett. 14:4613–4618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi EJ, Kim MS, Song SY, Yoo NJ and Lee
SH: Low frequent mutation of ARHGAP35, a candidate tumor suppressor
gene, in gastric and colorectal cancers. Pathol Oncol Res.
24:175–176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Johnstone CN, Castellví-Bel S, Chang LM,
Bessa X, Nakagawa H, Harada H, Sung RK, Piqué JM, Castells A and
Rustgi AK: ARHGAP8 is a novel member of the RHOGAP family related
to ARHGAP1/CDC42GAP/p50RHOGAP: Mutation and expression analyses in
colorectal and breast cancers. Gene. 336:59–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu G, Lu X, Huang T and Fan J: ARHGAP24
inhibits cell cycle progression, induces apoptosis and suppresses
invasion in renal cell carcinoma. Oncotarget. 7:51829–51839.
2016.PubMed/NCBI
|
|
15
|
Muller PAJ, Vousden KH and Norman JC: p53
and its mutants in tumor cell migration and invasion. J Cell Biol.
192:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dang WQ, Tang H, Cao H, Wang L and Chen
TM: Construction of lentivirus-mediated short hairpin RNA targeting
human STAT3 gene. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
28:1204–1207. 2012.(In Chinese). PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan Z, Liu X, Yu E, Wang H, Tang L, Wang H
and Fu C: Lentivirus-mediated RNA interference of tripartite motif
68 inhibits the proliferation of colorectal cancer cell lines
SW1116 and HCT116 in vitro. Oncol Lett. 13:2649–2655. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu K, Guo J, Wang H and Yu W: FRAT1
expression regulates proliferation in colon cancer cells. Oncol
Lett. 12:4761–4766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kasuya K, Nagakawa Y, Hosokawa Y, Sahara
Y, Takishita C, Nakajima T, Hijikata Y, Soya R, Katsumata K and
Tsuchida A: RhoA activity increases due to hypermethylation of
ARHGAP28 in a highly liver-metastatic colon cancer cell line.
Biomed Rep. 4:335–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kastan MB, Canman CE and Leonard CJ: P53,
cell cycle control and apoptosis: Implications for cancer. Cancer
Metastasis Rev. 14:3–15. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vaseva AV and Moll UM: The mitochondrial
p53 pathway. Biochim Biophys Acta. 1787:414–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim EM, Jung CH, Kim J, Hwang SG, Park JK
and Um HD: The p53/p21 complex regulates cancer cell invasion and
apoptosis by targeting Bcl-2 family proteins. Cancer Res.
77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao G, Zhu Y, Eno CO, Liu Y, Deleeuw L,
Burlison JA, Chaires JB, Trent JO and Li C: Activation of the
proapoptotic Bcl-2 protein Bax by a small molecule induces tumor
cell apoptosis. Mol Cell Biol. 34:1198–1207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bukholm IK and Nesland JM: Protein
expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb
in human colon carcinomas. Virchows Arch. 436:224–228. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katsumata K, Sumi T, Tomioka H, Aoki T and
Koyanagi Y: Induction of apoptosis by p53, bax, bcl-2, and p21
expressed in colorectal cancer. Int J Clin Oncol. 8:352–356. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
el-Deiry WS, Harper JW, O'Connor PM,
Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill
DE, Wang Y, et al: WAF1/CIP1 is induced in p53-mediated G1 arrest
and apoptosis. Cancer Res. 54:1169–1174. 1994.PubMed/NCBI
|
|
30
|
Kanavaros P, Stefanaki K, Valassiadou K,
Vlachonikolis J, Mavromanolakis M, Vlychou M, Kakolyris S,
Gorgoulis V, Tzardi M and Georgoulias V: Expression of p53,
p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal
adenocarcinomas. Med Oncol. 16:23–30. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miyashita T, Krajewski S, Krajewska M,
Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor
suppressor p53 is a regulator of bcl-2 and bax gene expression
in vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
|
|
32
|
Miyashita T and Reed JC: Tumor suppressor
p53 is a direct transcriptional activator of the human bax gene.
Cell. 80:293–299. 1995. View Article : Google Scholar : PubMed/NCBI
|
